EPCAM and cancer: In 2009, Maetzel et al. systematically proposed extracellular–nuclear signaling transduction for EpCAM, demonstrating that EpCAM is cleaved by RIP to release an EpICD fragment, which, in turn, interacts with components of the Wnt pathway to initiate gene expression in cancer cells (Figure 2) [29].